Literature DB >> 2725443

Prenatal cocaine: maternal toxicity, fetal effects and locomotor activity in rat offspring.

D E Hutchings1, T A Fico, D L Dow-Edwards.   

Abstract

Either 30 or 60 mg/kg of cocaine hydrochloride (COC) was administered by gastric intubation to gravid rats during the last two weeks of gestation. A pair-fed control group was administered the vehicle alone and allowed to eat and drink only the amount consumed by the 60 mg/kg group on the same gestation days. A nontreated control group was left undisturbed during pregnancy. All treated and control litters were fostered at birth to untreated dams. None of the treated dams died nor were any gross signs of cocaine toxicity observed. Among the COC-60 dams, there was a reduction in food and water intake at the beginning of treatment; whereas water intake returned to control levels, food intake remained approximately 12% below that of the controls. Compared to the nontreated dams, both COC-treated and pair-fed dams gained significantly less body weight from conception to term. Cocaine had no effect on offspring mortality, birthweight or rate of postnatal growth. Measurement of the ontogeny of motor activity during the first month of life revealed a similar activity pattern for all the groups except for the COC-60 group which showed heightened activity on Days 20 and 23. These findings are discussed in relation to other animal and clinical reports of prenatal cocaine exposure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725443     DOI: 10.1016/0892-0362(89)90087-1

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  12 in total

Review 1.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

2.  In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA.

Authors:  Camilla Bellone; Manuel Mameli; Christian Lüscher
Journal:  Nat Neurosci       Date:  2011-10-02       Impact factor: 24.884

3.  Development under the influence of cocaine. I. A comparison of the effects of daily cocaine treatment and resultant undernutrition on pregnancy and early growth in a large population of rats.

Authors:  R C Wiggins; B Ruiz
Journal:  Metab Brain Dis       Date:  1990-06       Impact factor: 3.584

4.  Effects of prenatal exposure to cocaine on the developing brain: anatomical, chemical, physiological and behavioral consequences.

Authors:  J A Harvey; A G Romano; M Gabriel; K J Simansky; W Du; V J Aloyo; E Friedman
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

Review 5.  Cocaine-induced neurodevelopmental deficits and underlying mechanisms.

Authors:  Melissa M Martin; Devon L Graham; Deirdre M McCarthy; Pradeep G Bhide; Gregg D Stanwood
Journal:  Birth Defects Res C Embryo Today       Date:  2016-06

6.  Interactive effects of prenatal cocaine and nicotine exposure on maternal toxicity, postnatal development and behavior in the rat.

Authors:  S K Sobrian; S F Ali; W Slikker; R R Holson
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

Review 7.  Neurodevelopmental effects of cocaine.

Authors:  L Singer; R Arendt; S Minnes
Journal:  Clin Perinatol       Date:  1993-03       Impact factor: 3.430

8.  Prenatal cocaine exposure revealed minimal postnatal changes in rat striatal dopamine D2 receptor sites and mRNA levels in the offspring.

Authors:  A Stadlin; H L Choi; K W Tsim; D Tsang
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

Review 9.  A meta-analysis of animal studies on disruption of spatial navigation by prenatal cocaine exposure.

Authors:  George H Trksak; Stephen J Glatt; Farzad Mortazavi; Denise Jackson
Journal:  Neurotoxicol Teratol       Date:  2007-06-30       Impact factor: 3.763

10.  Cocaine differentially inhibits neuronal differentiation and proliferation in vitro.

Authors:  D Zachor; J K Cherkes; C T Fay; I Ocrant
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.